| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |